Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Biosimilarity of UBLIN® vs NovoRapid® in Healthy Volunteers
NCT07600944Completed
- Sponsor
- The United Laboratories International Holdings
- Start
- May 2026
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in diabetes mellitus (DM) (2 arms), sponsored by The United Laboratories International Holdings. Primary endpoints: Area Under the Curve of Insulin Aspart Plasma Concentration From Time 0 to the Time of Last Measurable Concentration at 10 hours, Peak Plasma Concentration of Insulin Aspart at 10 hours and 2 more. Started May 2026; status: completed.
02
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07600944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07600944.